FDA Working on AI System for Import Screening
The Food and Drug Administration is working on a system for import screening that makes use of artificial intelligence, according to the agency’s fiscal year 2020 budget request. The agency is currently conducting research on the idea with the aim…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
of developing “an intelligent system by applying deep learning for screening and assessing import entry known as DeepSAFE,” FDA said. “This AI system will make the product evaluation and risk-assessment process at the ports of entry more robust.” FDA’s current screening system “uses various rules to determine a risk score that determines if the goods will require a manual review,” it said.